Variants such as GLP1R rs6923761 and FTO rs9939609 reveal individual differences in peptide pathway activation and weight-loss responsiveness
According to the Medicines and Healthcare products Regulatory Agency (MHRA) approved Summary of Product Characteristics (SmPC), dizziness is listed as an 'uncommon' side effect for Wegovy (affecting up to 1 in 100 people) and for Saxenda
One other benefit which is found with B12 shots, are the effects they have for anti-aging
GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast Cancer
Results May Vary: Individual results will vary based on factors including age, baseline health condition, lifestyle factors, consistency of use, genetic factors, current medications, diet and exercise habits, and other individual variables